C12N 2770/24044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2770/24044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 4
- Assignees
- 2
- Inventors
- 3
- Latest grant
- 11 Oct 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Dengue vaccine unit dose and administration thereof25 Jun 2026US 2026/0174812 A1Takeda Vaccines, Inc.
- Next generation mrna vaccines20 Mar 2025US 2025/0090648 A1FuTr Bio Ltda.
- Dengue vaccine unit dose and administration thereof27 Jul 2023US 2023/0233628 A1Takeda Vaccines, Inc.
- Dengue vaccine unit dose and administration thereof5 Mar 2020US 2020/0069751 A1Takeda Vaccines, Inc.
Most cited
By later US patents